loadpatents
name:-0.18349695205688
name:-0.042623996734619
name:-0.03298807144165
Roche Glycart AG Patent Filings

Roche Glycart AG

Patent Applications and Registrations

Patent applications and USPTO patent grants for Roche Glycart AG.The latest application filed is for "anti-fap antibodies and methods of use".

Company Profile
64.105.200
  • Roche Glycart AG - Schlieren CH
  • ROCHE GLYCART AG - N/A
  • Roche GlycArt AG - Schlieren-Zurich CH
  • ROCHE GLYCART AG -
  • ROCHE GLYCART AG - CH CH
  • Roche Glycart AG - Schilieren CH
  • Roche GlycArt AG - Switzerland DE
  • Roche Glycart AG - Schileren CH
  • ROCHE GLYCART AG; - Schlieren CH
  • Roche GlycArt AG - Zurich CH
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Anti-fap Antibodies And Methods Of Use
App 20220281995 - BACAC; Marina ;   et al.
2022-09-08
Novel Immunoconjugates
App 20220242971 - AST; Oliver ;   et al.
2022-08-04
Interleukin-2 fusion proteins and uses thereof
Grant 11,365,232 - Hosse , et al. June 21, 2
2022-06-21
Anti-FAP antibodies and methods of use
Grant 11,332,545 - Bacac , et al. May 17, 2
2022-05-17
Bispecific T Cell Activating Antigen Binding Molecules
App 20220064296 - BACAC; Marina ;   et al.
2022-03-03
Anti-cea Antibodies
App 20220002441 - Hofer; Thomas U. ;   et al.
2022-01-06
Antibodies specific for DR5 and methods of use
Grant 11,214,622 - Bruenker , et al. January 4, 2
2022-01-04
Aspgr Antibodies And Uses Thereof
App 20210324085 - Hofer; Thomas ;   et al.
2021-10-21
Immunoconjugates
Grant 11,130,822 - Ast , et al. September 28, 2
2021-09-28
Mutant interleukin-2 polypeptides
Grant 11,111,312 - Ast , et al. September 7, 2
2021-09-07
Bispecific T Cell Activating Antigen Binding Molecules
App 20210253704 - BACAC; Marina ;   et al.
2021-08-19
Bispecific T Cell Activating Antigen Binding Molecules
App 20210253703 - BACAC; Marina ;   et al.
2021-08-19
Antibody Fc Variants
App 20210139603 - BAEHNER; Monika ;   et al.
2021-05-13
ASPGR antibodies and uses thereof
Grant 10,975,151 - Hofer , et al. April 13, 2
2021-04-13
Bispecific T Cell Activating Antigen Binding Molecules
App 20210101979 - BACAC; Marina ;   et al.
2021-04-08
Bispecific Anti-vegf/anti-ang-2 Antibodies And Their Use In The Treatment Of Ocular Vascular Diseases
App 20210095013 - Duerr; Harald ;   et al.
2021-04-01
Antigen Binding Molecules With Increased Fc Receptor Binding Affinity And Effector Function
App 20210002382 - UMANA; Pablo ;   et al.
2021-01-07
Bispecific T Cell Activating Antigen Binding Molecules
App 20200385470 - BACAC; Marina ;   et al.
2020-12-10
Antigen Binding Molecules That Bind EGFR, Vectors Encoding Same, and Uses Thereof
App 20200332012 - UMANA; Pablo ;   et al.
2020-10-22
Bispecific T cell activating antigen binding molecules
Grant 10,781,258 - Bacac , et al. Sept
2020-09-22
Bispecific T cell activating antigen binding molecules
Grant 10,781,257 - Bacac , et al. Sept
2020-09-22
Combination Il-2 Immunoconjugate Therapy
App 20200197492 - GERDES; Christian ;   et al.
2020-06-25
Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases
Grant 10,683,345 - Duerr , et al.
2020-06-16
Interleukin-2 Fusion Proteins And Uses Thereof
App 20200172591 - Hosse; Ralf ;   et al.
2020-06-04
Aspgr Antibodies And Uses Thereof
App 20200102392 - Hofer; Thomas ;   et al.
2020-04-02
Combination IL-2 immunoconjugate therapy
Grant 10,603,360 - Gerdes , et al.
2020-03-31
Anti-fap Antibodies And Methods Of Use
App 20200079873 - BACAC; Marina ;   et al.
2020-03-12
Anti-FAP antibodies and methods of use
Grant 10,577,429 - Bacac , et al.
2020-03-03
Interleukin-2 fusion proteins and uses thereof
Grant 10,562,949 - Hosse , et al. Feb
2020-02-18
Mutant Interleukin-2 Polypeptides
App 20190322765 - Ast; Oliver ;   et al.
2019-10-24
Novel Immunoconjugates
App 20190322763 - AST; Oliver ;   et al.
2019-10-24
Novel Immunoconjugates
App 20190315883 - AST; Oliver ;   et al.
2019-10-17
A-fucosylation detection in antibodies
Grant 10,352,943 - Jaeger , et al. July 16, 2
2019-07-16
Anti-cea Antibodies
App 20190185583 - Hofer; Thomas U. ;   et al.
2019-06-20
Mutant interleukin-2 polypeptides
Grant 10,323,098 - Ast , et al.
2019-06-18
Bispecific T Cell Activating Antigen Binding Molecules
App 20190177413 - BACAC; Marina ;   et al.
2019-06-13
Immunoconjugates
Grant 10,316,104 - Ast , et al.
2019-06-11
Removal Of Cancer Cells By Circulating Virus-specific Cytotoxic T-cells Using Cancer Cell Targeted Mhc Class 1 Compromising Mult
App 20190169309 - Klein; Christian ;   et al.
2019-06-06
Antigen Binding Molecules That Bind EGFR, Vectors Encoding Same, and Uses Thereof
App 20190106497 - Umana; Pablo ;   et al.
2019-04-11
Anti-FAP antibodies and methods of use
Grant 10,253,110 - Bacac , et al.
2019-04-09
Mutant Interleukin-2 Polypeptides
App 20190077881 - Ast; Oliver ;   et al.
2019-03-14
Bispecific Antibodies Specific For Fap And Dr5, Antibodies Specific For Dr5 And Methods Of Use
App 20190062453 - Bruenker; Peter ;   et al.
2019-02-28
Immunoconjugates
Grant 10,202,464 - Ast , et al. Feb
2019-02-12
Anti-HER3 antibodies and uses thereof
Grant 10,196,456 - Bossenmaier , et al. Fe
2019-02-05
Aspgr Antibodies And Uses Thereof
App 20190031760 - HOFER; Thomas ;   et al.
2019-01-31
Mutant interleukin-2 polypeptides
Grant 10,184,009 - Ast , et al. Ja
2019-01-22
Bispecific T Cell Activating Antigen Binding Molecules
App 20190002564 - BACAC; Marina ;   et al.
2019-01-03
Bispecific T Cell Activating Antigen Binding Molecules
App 20190002565 - BACAC; Marina ;   et al.
2019-01-03
Bispecific T cell activating antigen binding molecules
Grant 10,155,815 - Bacac , et al. Dec
2018-12-18
Bispecific T Cell Activating Antigen Binding Molecules
App 20180312589 - BACAC; Marina ;   et al.
2018-11-01
Bispecific antibodies
Grant 10,106,600 - Brinkmann , et al. October 23, 2
2018-10-23
Fc-free antibodies comprising two fab-fragments and methods of use
Grant 10,087,250 - Bruenker , et al. October 2, 2
2018-10-02
ASPGR antibodies and uses thereof
Grant 10,087,254 - Hofer , et al. October 2, 2
2018-10-02
Bispecific T Cell Activating Antigen Binding Molecules
App 20180273643 - AST; Oliver ;   et al.
2018-09-27
Separation Method For Fucosylated Antibodies
App 20180265544 - Freimoser-Grundschober; Anne ;   et al.
2018-09-20
Interleukin-10 fusion proteins and uses thereof
Grant 10,040,843 - Duerner , et al. August 7, 2
2018-08-07
Separation method for fucosylated antibodies
Grant 9,994,610 - Freimoser-Grundschober , et al. June 12, 2
2018-06-12
Mutant Interleukin-2 Polypeptides
App 20180142037 - AST; Oliver ;   et al.
2018-05-24
Aspgr Antibodies And Uses Thereof
App 20180118833 - HOFER; Thomas ;   et al.
2018-05-03
Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
Grant 9,957,326 - Umana , et al. May 1, 2
2018-05-01
Bispecific T Cell Activating Antigen Binding Molecules
App 20180086849 - Bacac; Marina ;   et al.
2018-03-29
Bispecific antibodies specific for FAP and DR5, antibodies specific for DR5
Grant 9,926,379 - Bruenker , et al. March 27, 2
2018-03-27
Anti-cea Antibodies
App 20180079827 - Hofer; Thomas U. ;   et al.
2018-03-22
Interleukin-2 Fusion Proteins And Uses Thereof
App 20180009868 - Hosse; Ralf ;   et al.
2018-01-11
ASGPR antibodies and uses thereof
Grant 9,771,427 - Hofer , et al. September 26, 2
2017-09-26
Bispecific Anti-vegf/anti-ang-2 Antibodies And Their Use In The Treatment Of Ocular Vascular Diseases
App 20170260265 - Duerr; Harald ;   et al.
2017-09-14
Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
Grant 9,718,885 - Umana , et al. August 1, 2
2017-08-01
Bispecific Antigen Binding Molecules
App 20170198043 - Auer; Johannes ;   et al.
2017-07-13
Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases
Grant 9,695,233 - Duerr , et al. July 4, 2
2017-07-04
Anti-her3 Antibodies And Uses Thereof
App 20170174784 - Bossenmaier; Birgit ;   et al.
2017-06-22
METHOD AND CONSTRUCTS FOR THE pH DEPENDENT PASSAGE OF THE BLOOD-BRAIN-BARRIER
App 20170174776 - Bohrmann; Bernd ;   et al.
2017-06-22
Antibody Fc Variants
App 20170137530 - BAEHNER; Monika ;   et al.
2017-05-18
Bispecific anti-EGFR/anti IGF-1R antibodies
Grant 9,650,442 - Hosse , et al. May 16, 2
2017-05-16
Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
Grant 9,631,023 - Umana , et al. April 25, 2
2017-04-25
A-fucosylation Detection In Antibodies
App 20170108510 - Jaeger; Christiane ;   et al.
2017-04-20
Anti-HER3 antibodies and uses thereof
Grant 9,611,331 - Bossenmaier , et al. April 4, 2
2017-04-04
Novel Immunoconjugates
App 20170088631 - Ast; Oliver ;   et al.
2017-03-30
Combination Il-2 Immunoconjugate Therapy
App 20170056522 - Gerdes; Christian ;   et al.
2017-03-02
Combination IL-2 immunoconjugate therapy
Grant 9,526,797 - Gerdes , et al. December 27, 2
2016-12-27
Interleukin-10 Fusion Proteins And Uses Thereof
App 20160340413 - Duerner; Lydia Jasmin ;   et al.
2016-11-24
DR5--FAP bispecific death receptor agonistic antibodies
Grant 9,481,730 - Bruenker , et al. November 1, 2
2016-11-01
Antigen Binding Molecules That Bind EGFR, Vectors Encoding Same, and Uses Thereof
App 20160304614 - UMANA; Pablo ;   et al.
2016-10-20
Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
App 20160272719 - Umana; Pablo ;   et al.
2016-09-22
Immunoconjugates
Grant 9,447,159 - Ast , et al. September 20, 2
2016-09-20
Anti-tenascin-c A2 Antibodies And Methods Of Use
App 20160264651 - Freimoser-Grundschober; Anne ;   et al.
2016-09-15
Novel Immunoconjugates
App 20160263240 - Ast; Oliver ;   et al.
2016-09-15
Anti-cea Antibodies
App 20160229923 - Hofer; Thomas U. ;   et al.
2016-08-11
Glycosylation Engineering of Antibodies for Improving Antibody-Dependent Cellular Cytotoxicity
App 20160208009 - Umana; Pablo ;   et al.
2016-07-21
Mutant Interleukin-2 Polypeptides
App 20160208017 - Ast; Oliver ;   et al.
2016-07-21
Multispecific antibodies comprising full length antibodies and single chain fab fragments
Grant 9,382,323 - Brinkmann , et al. July 5, 2
2016-07-05
Combination Therapy Of An Afucosylated Cd20 Antibody With Bendamustine
App 20160166688 - HERTING; FRANK ;   et al.
2016-06-16
Predictive biomarker for cancer treatment with ADCC-enhanced antibodies
Grant 9,360,481 - Di Scala , et al. June 7, 2
2016-06-07
Bispecific T Cell Activating Antigen Binding Molecules
App 20160145354 - BACAC; MARINA ;   et al.
2016-05-26
Interleukin-10 fusion proteins
Grant 9,346,872 - Duerner , et al. May 24, 2
2016-05-24
Humanized anti-CDCP1 antibodies
Grant 9,346,886 - Auer , et al. May 24, 2
2016-05-24
Fc-free antibodies comprising two Fab-fragments and methods of use
App 20160130347 - Bruenker; Peter ;   et al.
2016-05-12
Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
Grant 9,321,843 - Umana , et al. April 26, 2
2016-04-26
Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
Grant 9,309,317 - Umana , et al. April 12, 2
2016-04-12
Anti-MCSP antibodies
Grant 9,309,306 - Freytag , et al. April 12, 2
2016-04-12
Interleukin-2 Fusion Proteins And Uses Thereof
App 20160090407 - Hosse; Ralf ;   et al.
2016-03-31
Polynucleotides encoding anti-CD20 antigen binding molecules with increased Fc receptor binding affinity and effector function
Grant 9,296,820 - Umana , et al. March 29, 2
2016-03-29
Removal of Cancer Cells by Circulating Virus-Specific Cytotoxic T-Cells Using Cancer Cell Targeted MHC Class 1 Compromising Multi-Function Proteins
App 20160083477 - Klein; Christian ;   et al.
2016-03-24
ANTIGEN BINDING MOLECULES WITH INCREASED Fc RECEPTOR BINDING AFFINITY AND EFFECTOR FUNCTION
App 20160075794 - UMANA; Pablo ;   et al.
2016-03-17
ANTIGEN BINDING MOLECULES WITH INCREASED Fc RECEPTOR BINDING AFFINITY AND EFFECTOR FUNCTION
App 20160075793 - UMANA; Pablo ;   et al.
2016-03-17
ANTIGEN BINDING MOLECULES WITH INCREASED Fc RECEPTOR BINDING AFFINITY AND EFFECTOR FUNCTION
App 20160076009 - UMANA; Pablo ;   et al.
2016-03-17
Antibodies to Carcinoembryonic Antigen (CEA), Methods of Making Same, and Uses Thereof
App 20160075795 - MOSSNER; Ekkehard ;   et al.
2016-03-17
In Vivo Adcc Model
App 20160058891 - Breustedt; Daniel ;   et al.
2016-03-03
Anti-fap Antibodies And Methods Of Use
App 20160060357 - Bacac; Marina ;   et al.
2016-03-03
Anti-fap Antibodies And Methods Of Use
App 20160060356 - Bacac; Marina ;   et al.
2016-03-03
Mutant interleukin-2 polypeptides
Grant 9,266,938 - Ast , et al. February 23, 2
2016-02-23
Combination Therapy Of An Afucosylated Cd20 Antibody With An Anti-vegf
App 20160017050 - Herting; Frank ;   et al.
2016-01-21
Combination Therapy Of A Type Ii Anti-cd20 Antibody With A Proteasome Inhibitor
App 20160000912 - FERTIG; GEORG ;   et al.
2016-01-07
Combination Therapy Of A Type Ii Anti-cd20 Antibody With Increased Antibody Dependent Cellular Cytotoxity (adcc)
App 20160000911 - DUMONTET; CHARLES ;   et al.
2016-01-07
Anti-CEA antibodies
Grant 9,206,260 - Hofer , et al. December 8, 2
2015-12-08
Modified Antigen Binding Molecules With Altered Cell Signaling Activity
App 20150344584 - Umana; Pablo ;   et al.
2015-12-03
Asgpr Antibodies And Uses Thereof
App 20150299324 - Hofer; Thomas ;   et al.
2015-10-22
Anti-tenascin-C A2 antibodies and methods of use
Grant 9,156,913 - Freimoser-Grundschober , et al. October 13, 2
2015-10-13
Bispecific Antibodies Specific For T-cell Activating Antigens And A Tumor Antigen And Methods Of Use
App 20150274845 - Bruenker; Peter ;   et al.
2015-10-01
Combination Therapy Of An Afucosylated Cd20 Antibody With Fludarabine And/or Mitoxantrone
App 20150274834 - Dreyling; Martin ;   et al.
2015-10-01
Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
App 20150274837 - UMANA; Pablo ;   et al.
2015-10-01
COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A mTOR INHIBITOR
App 20150265703 - Herting; Frank ;   et al.
2015-09-24
Antibody Fc Variants
App 20150239981 - BAEHNER; Monika ;   et al.
2015-08-27
Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
Grant 9,074,008 - Umana , et al. July 7, 2
2015-07-07
Antibodies to carcinoembryonic antigen (CEA), methods of making same, and uses thereof
Grant 9,068,008 - Mossner , et al. June 30, 2
2015-06-30
Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
Grant 9,068,005 - Umana , et al. June 30, 2
2015-06-30
Anti-FAP antibodies and methods of use
Grant 9,011,847 - Bacac , et al. April 21, 2
2015-04-21
Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
Grant 8,999,324 - Umana , et al. April 7, 2
2015-04-07
Combination Therapy Of An Afucosylated Cd20 Antibody With Bendamustine
App 20150093376 - HERTING; FRANK ;   et al.
2015-04-02
Combination Therapy
App 20150079023 - KLEIN; CHRISTIAN ;   et al.
2015-03-19
Combination Therapy Of An Afucosylated Cd20 Antibody With Fludarabine And/or Mitoxantrone
App 20150079073 - DREYLING; MARTIN ;   et al.
2015-03-19
COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A mTOR INHIBITOR
App 20150071911 - HERTING; FRANK ;   et al.
2015-03-12
Antibody Fc variants
Grant 8,969,526 - Baehner , et al. March 3, 2
2015-03-03
Anti-her3 Antibodies And Uses Thereof
App 20140377272 - Bossenmaier; Birgit ;   et al.
2014-12-25
Anti-her3 Antibodies And Uses Thereof
App 20140377273 - Bossenmaier; Birgit ;   et al.
2014-12-25
Bispecific Antibodies Specific For Fap And Dr5, Antibodies Specific For Dr5 And Methods Of Use
App 20140370019 - Bruenker; Peter ;   et al.
2014-12-18
Antigen binding molecules with increased Fc receptor binding affinity and effector function
Grant 8,883,980 - Umana , et al. November 11, 2
2014-11-11
Combination Therapy Of An Afucosylated Cd20 Antibody With An Anti-vegf Antibody
App 20140322200 - HERTING; FRANK ;   et al.
2014-10-30
Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function
Grant 8,859,234 - Umana , et al. October 14, 2
2014-10-14
Anti-HER3 antibodies and uses thereof
Grant 8,859,737 - Bossenmaier , et al. October 14, 2
2014-10-14
A-fucosylation Detection In Antibodies
App 20140302544 - Jaeger; Christiane ;   et al.
2014-10-09
Combination Therapy With Type I And Type Ii Anti-cd20 Antibodies
App 20140294807 - FRIESS; THOMAS ;   et al.
2014-10-02
Separation Method For Fucosylated Antibodies
App 20140255399 - Freimoser-Grundschober; Anne ;   et al.
2014-09-11
Bispecific T Cell Activating Antigen Binding Molecules
App 20140242080 - Jaeger; Christiane ;   et al.
2014-08-28
Anti-mcsp Antibodies
App 20140242083 - Hofer; Thomas ;   et al.
2014-08-28
Bispecific T Cell Activating Antigen Binding Molecules
App 20140242079 - Bacac; Marina ;   et al.
2014-08-28
Predictive biomarker for cancer treatment with ADCC-enhanced antibodies
App 20140227256 - Di Scala; Lilla ;   et al.
2014-08-14
Antigen Binding Molecules That Bind EGFR, Vectors Encoding Same, and Uses Thereof
App 20140227253 - UMANA; Pablo ;   et al.
2014-08-14
Anti-CEA Antibodies
App 20140212408 - Hofer; Thomas U. ;   et al.
2014-07-31
Bispecific Anti-egfr/anti Igf-1r Antibodies
App 20140193415 - Hosse; Ralf ;   et al.
2014-07-10
Combination Therapy Of An Afucosylated Cd20 Antibody With A Mdm2 Inhibitor
App 20140140988 - ELDERING; ERIC ;   et al.
2014-05-22
Bispecific Anti ErbB3 / Anti cMet Antibodies
App 20140135482 - Bossenmaier; Birgit ;   et al.
2014-05-15
Immunotherapy
App 20140072528 - Gerdes; Christian ;   et al.
2014-03-13
Fusion Constructs and Use of Same to Produce Antibodies with Increased Fc Receptor Binding Affinity and Effector Function
App 20140073005 - UMANA; PABLO ;   et al.
2014-03-13
Immunotherapy
App 20140065097 - Gerdes; Christian ;   et al.
2014-03-06
Combination Therapy Of A Type Ii Anti-cd20 Antibody With Increased Antibody Dependent Cellular Cytotoxity (adcc)
App 20140065134 - DUMONTET; CHARLES ;   et al.
2014-03-06
Interleukin-2 Fusion Proteins And Uses Thereof
App 20140044675 - Hosse; Ralf ;   et al.
2014-02-13
Interleukin-10 Fusion Proteins And Uses Thereof
App 20140044674 - Duerner; Lydia Jasmin ;   et al.
2014-02-13
Combination Therapy Of An Afucosylated Cd20 Antibody With Bendamustine
App 20140044705 - HERTING; FRANK ;   et al.
2014-02-13
Anti-CEA antibodies
Grant 8,642,742 - Hofer , et al. February 4, 2
2014-02-04
Bispecific Anti-VEGF/Anti-ANG-2 Antibodies and their use in the Treatment of Ocular Vascular Diseases
App 20140017244 - Duerr; Harald ;   et al.
2014-01-16
Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
Grant 8,629,248 - Umana , et al. January 14, 2
2014-01-14
Combination Therapy Of An Afucosylated Cd20 Antibody With Fludarabine And/or Mitoxantrone
App 20140010804 - DREYLING; MARTIN ;   et al.
2014-01-09
Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
Grant 8,623,644 - Umana , et al. January 7, 2
2014-01-07
Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
Grant 8,614,065 - Umana , et al. December 24, 2
2013-12-24
Combination Therapy
App 20130302274 - KLEIN; CHRISTIAN ;   et al.
2013-11-14
COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A mTOR INHIBITOR
App 20130280243 - HERTING; FRANK ;   et al.
2013-10-24
Predictive Biomarker For Cancer Treatment With Adcc-enhanced Antibodies
App 20130273032 - Gerdes; Christian ;   et al.
2013-10-17
Bispecific Anti ErbB2/Anti cMet Antibodies
App 20130273054 - Bossenmaier; Birgit ;   et al.
2013-10-17
Activatable Bispecific Antibodies
App 20130266568 - BRINKMANN; ULRICH ;   et al.
2013-10-10
Humanized Anti-CDCP1 Antibodies
App 20130209455 - Auer; Johannes ;   et al.
2013-08-15
Predictive Biomarker For Cancer Treatment With Adcc-enhanced Antibodies
App 20130195854 - Gerdes; Christian ;   et al.
2013-08-01
Bispecific Anti ErbB1 / Anti cMet Antibodies
App 20130156772 - Bossenmaier; Birgit ;   et al.
2013-06-20
Humanized anti-CDCP1 antibodies
Grant 8,394,928 - Auer , et al. March 12, 2
2013-03-12
Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function
Grant 8,367,374 - Umana , et al. February 5, 2
2013-02-05
Method and Constructs for the pH Dependent Passage of the Blood-brain-barrier
App 20120282176 - Bohrmann; Bernd ;   et al.
2012-11-08
Anti-cea Antibodies
App 20120251529 - Hofer; Thomas U. ;   et al.
2012-10-04
Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
Grant 8,273,328 - Umana , et al. September 25, 2
2012-09-25
Bispecific Death Receptor Agonistic Antibodies
App 20120184718 - Bruenker; Peter ;   et al.
2012-07-19
Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
Grant 8,097,436 - Umana , et al. January 17, 2
2012-01-17
Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
Grant 8,088,380 - January 3, 2
2012-01-03
Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
Grant 8,021,856 - Umana , et al. September 20, 2
2011-09-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed